Vericel (VCEL) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to 5.11%.
- Vericel's EBIT Margin rose 93700.0% to 5.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.75%, marking a year-over-year increase of 32900.0%. This contributed to the annual value of 1.9% for FY2024, which is 51800.0% up from last year.
- As of Q3 2025, Vericel's EBIT Margin stood at 5.11%, which was up 93700.0% from 3.21% recorded in Q2 2025.
- Vericel's 5-year EBIT Margin high stood at 24.52% for Q4 2024, and its period low was 24.52% during Q2 2022.
- For the 5-year period, Vericel's EBIT Margin averaged around 6.53%, with its median value being 10.66% (2024).
- Over the last 5 years, Vericel's EBIT Margin had its largest YoY gain of 323200bps in 2021, and its largest YoY loss of -252800bps in 2021.
- Quarter analysis of 5 years shows Vericel's EBIT Margin stood at 8.7% in 2021, then soared by 33bps to 11.55% in 2022, then skyrocketed by 70bps to 19.59% in 2023, then increased by 25bps to 24.52% in 2024, then tumbled by -79bps to 5.11% in 2025.
- Its EBIT Margin stands at 5.11% for Q3 2025, versus 3.21% for Q2 2025 and 24.32% for Q1 2025.